JAMISON, Pa.--(BUSINESS WIRE)--Quinnova Pharmaceuticals, Inc. is proud to announce the commercial launch of its Atrapro™ brand with two products, Atrapro™ Antipruritic Hydrogel and Atrapro™ Dermal Spray with Preservatives. Each product formulation features patented Microcyn®, providing steroid-free, non-cytotoxic, and non-irritating relief.
